2002 exposure to fluoroquinolones. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Achilles Tendon

Organisms34

Streptococcus pneumoniae Staphylococcus aureus Mycoplasma hominis Clostridium difficile Mycobacterium fortuitum Gram-Negative Bacteria Escherichia coli Pseudomonas aeruginosa Gram-Positive Bacteria Neisseria gonorrhoeae Salmonella typhi Laurus Bartonella bacilliformis Gram-Positive Cocci Mycobacterium tuberculosis Campylobacter Moraxella (Branhamella) catarrhalis Klebsiella pneumoniae Salmonella paratyphi A Salmonella enterica Bacteria, Anaerobic Enterobacteriaceae Bacteroides fragilis Campylobacter jejuni Bacteria Acinetobacter Campylobacter coli Haemophilus influenzae Shigella sonnei Mycoplasma bovis Mycobacterium smegmatis Stenotrophomonas maltophilia Salmonella Enterobacter cloacae

Diseases30

Dermatitis, Phototoxic Gram-Negative Bacterial Infections Pneumococcal Infections Bacterial Infections Typhoid Fever Community-Acquired Infections Urinary Tract Infections Escherichia coli Infections Enterocolitis, Pseudomembranous Paratyphoid Fever Cross Infection Gram-Positive Bacterial Infections Otitis Externa Gonorrhea Respiratory Tract Infections Campylobacter Infections Extensively Drug-Resistant Tuberculosis Clostridium Infections Pseudomonas Infections Eye Infections, Bacterial Tuberculosis, Multidrug-Resistant Dermatitis, Photoallergic Staphylococcal Infections Klebsiella Infections Salmonella Infections Pneumonia, Bacterial Bacteremia Tendinopathy Enterobacteriaceae Infections Bronchitis, Chronic

Chemicals and Drugs49

Fluoroquinolones Anti-Infective Agents Ciprofloxacin Ofloxacin DNA Gyrase Aza Compounds Levofloxacin DNA Topoisomerase IV Quinolones Norfloxacin Anti-Bacterial Agents Pefloxacin Naphthyridines Quinolines Enoxacin 4-Quinolones DNA Topoisomerases, Type II Nalidixic Acid Topoisomerase II Inhibitors Macrolides Fleroxacin beta-Lactams Nitrofurantoin Aminoglycosides DNA, Bacterial Capreomycin Antitubercular Agents Bacterial Proteins Anti-Infective Agents, Urinary Cephalosporins beta-Lactamases Trimethoprim-Sulfamethoxazole Combination Tetracyclines Carbapenems Ethambutol Dioxolanes Lactams Erythromycin Ketolides Minocycline Membrane Transport Proteins DNA Topoisomerases Rifampin Ethidium Streptogramin B Reserpine Tetracycline Chloramphenicol Azithromycin

Analytical, Diagnostic and Therapeutic Techniques and Equipment8

Microbial Sensitivity Tests Chromatography, Supercritical Fluid Serum Bactericidal Test Electrophoresis, Gel, Pulsed-Field Ribotyping Area Under Curve Colony Count, Microbial Sequence Analysis, DNA

Phenomena and Processes12

Drug Resistance, Bacterial Drug Resistance, Microbial Drug Resistance, Multiple, Bacterial Mutation Drug Resistance, Multiple beta-Lactam Resistance Area Under Curve Genes, Bacterial Cephalosporin Resistance Drug Interactions Methicillin Resistance Plasmids

Information Science1

Molecular Sequence Data

Health Care3

Drug Utilization Area Under Curve Hospitals

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Fluoroquinolones Anti-Infective Agents Ciprofloxacin Ofloxacin DNA Gyrase Aza Compounds Levofloxacin Microbial Sensitivity Tests DNA Topoisomerase IV Quinolones Norfloxacin Anti-Bacterial Agents Drug Resistance, Bacterial Pefloxacin Naphthyridines Quinolines Enoxacin Drug Resistance, Microbial 4-Quinolones Drug Resistance, Multiple, Bacterial DNA Topoisomerases, Type II Streptococcus pneumoniae Dermatitis, Phototoxic Nalidixic Acid Topoisomerase II Inhibitors Gram-Negative Bacterial Infections Macrolides Fleroxacin Staphylococcus aureus Mycoplasma hominis beta-Lactams Clostridium difficile Pneumococcal Infections Mutation Bacterial Infections Typhoid Fever Mycobacterium fortuitum Gram-Negative Bacteria Escherichia coli Nitrofurantoin Aminoglycosides Pseudomonas aeruginosa DNA, Bacterial Gram-Positive Bacteria Capreomycin Community-Acquired Infections Antitubercular Agents Drug Resistance, Multiple Drug Utilization Urinary Tract Infections Bacterial Proteins Escherichia coli Infections Enterocolitis, Pseudomembranous Paratyphoid Fever Neisseria gonorrhoeae Cross Infection Anti-Infective Agents, Urinary Cephalosporins Salmonella typhi Laurus Bartonella bacilliformis Gram-Positive Cocci beta-Lactamases Mycobacterium tuberculosis Campylobacter Moraxella (Branhamella) catarrhalis Gram-Positive Bacterial Infections Otitis Externa Gonorrhea Respiratory Tract Infections Klebsiella pneumoniae Salmonella paratyphi A Salmonella enterica Bacteria, Anaerobic Trimethoprim-Sulfamethoxazole Combination Tetracyclines Campylobacter Infections Carbapenems beta-Lactam Resistance Extensively Drug-Resistant Tuberculosis Chromatography, Supercritical Fluid Clostridium Infections Serum Bactericidal Test Electrophoresis, Gel, Pulsed-Field Enterobacteriaceae Ethambutol Dioxolanes Ribotyping Area Under Curve Lactams Bacteroides fragilis Genes, Bacterial Erythromycin Colony Count, Microbial Pseudomonas Infections Eye Infections, Bacterial Campylobacter jejuni Bacteria Ketolides Tuberculosis, Multidrug-Resistant

No FAQ available that match "2002 exposure to fluoroquinolones"